Healthcare provider profile · identity verified

Michael Tawadrous, M.D.

Family Practice · CHANDLER, AZ · NPI 1972892339

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	456	70
Atorvastatin Calcium	Atorvastatin Calcium	382	81
Levothyroxine Sodium	Levothyroxine Sodium	301	46
Pantoprazole Sodium	Pantoprazole Sodium	242	45
Eliquis	Apixaban	238	45
Furosemide	Furosemide	235	50
Tamsulosin Hcl	Tamsulosin Hcl	190	34
Amlodipine Besylate	Amlodipine Besylate	166	41
Metformin Hcl	Metformin Hcl	156	24
Potassium Chloride	Potassium Chloride	148	30
Lisinopril	Lisinopril	147	34
Sertraline Hcl	Sertraline Hcl	144	24
Metoprolol Tartrate	Metoprolol Tartrate	133	31
Trazodone Hcl	Trazodone Hcl	115	31
Clopidogrel	Clopidogrel Bisulfate	112	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	105	20
Mirtazapine	Mirtazapine	105	17
Baclofen	Baclofen	95	17
Famotidine	Famotidine	94	24
Metoprolol Succinate	Metoprolol Succinate	87	20
Donepezil Hcl	Donepezil Hcl	86	15
Hydroxyzine Hcl	Hydroxyzine Hcl	85	21
Losartan Potassium	Losartan Potassium	83	30
Hydralazine Hcl	Hydralazine Hcl	80	17
Levetiracetam	Levetiracetam	80	18
Montelukast Sodium	Montelukast Sodium	74	13
Memantine Hcl	Memantine Hcl	73	17
Sucralfate	Sucralfate	70	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	69	17
Simvastatin	Simvastatin	69	suppressed
Warfarin Sodium	Warfarin Sodium	69	suppressed
Ondansetron Hcl	Ondansetron Hcl	67	19
Albuterol Sulfate Hfa	Albuterol Sulfate	65	23
Carvedilol	Carvedilol	65	15
Bumetanide	Bumetanide	64	suppressed
Divalproex Sodium	Divalproex Sodium	60	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	60	suppressed
Jardiance	Empagliflozin	59	11
Duloxetine Hcl	Duloxetine Hcl	55	16
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	54	17
Nifedipine Er	Nifedipine	54	14
Rosuvastatin Calcium	Rosuvastatin Calcium	52	11
Pravastatin Sodium	Pravastatin Sodium	51	suppressed
Methocarbamol	Methocarbamol	47	22
Quetiapine Fumarate	Quetiapine Fumarate	47	14
Olanzapine	Olanzapine	46	suppressed
Latanoprost	Latanoprost	44	suppressed
Cefdinir	Cefdinir	43	27
Atenolol	Atenolol	41	suppressed
Topiramate	Topiramate	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	40	14
Lamotrigine	Lamotrigine	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Sodium Chloride	0.9 % Sodium Chloride	40	11
Spironolactone	Spironolactone	40	11
Midodrine Hcl	Midodrine Hcl	39	suppressed
Tizanidine Hcl	Tizanidine Hcl	38	suppressed
Finasteride	Finasteride	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	35	18
Omeprazole	Omeprazole	35	13
Buspirone Hcl	Buspirone Hcl	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	33	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	31	suppressed
Clonidine Hcl	Clonidine Hcl	31	12
Lactulose	Lactulose	29	14
Nystatin	Nystatin	29	16
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	suppressed
Xarelto	Rivaroxaban	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Verapamil Er	Verapamil Hcl	25	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	24	suppressed
Oxcarbazepine	Oxcarbazepine	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Admelog Solostar	Insulin Lispro	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Valsartan	Valsartan	22	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Prednisone	Prednisone	21	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	20	20
Aripiprazole	Aripiprazole	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Acetic Acid	Acetic Acid	19	suppressed
Allopurinol	Allopurinol	19	suppressed
Cephalexin	Cephalexin	19	suppressed
Methotrexate	Methotrexate Sodium	19	suppressed
Carbamazepine Er	Carbamazepine	18	suppressed
Cefazolin Sodium	Cefazolin Sodium	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Meropenem	Meropenem	18	suppressed
Restasis	Cyclosporine	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Brilinta	Ticagrelor	17	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Prednisolone Acetate	Prednisolone Acetate	17	suppressed
Primidone	Primidone	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Glipizide	Glipizide	16	suppressed
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Risperidone	Risperidone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Movantik	Naloxegol Oxalate	13	suppressed
Phenytoin	Phenytoin	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Dutasteride	Dutasteride	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	11	suppressed
Nystop	Nystatin	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error